Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Specific Biomarkers of Immune-mediated Hepatitis Secondary to Immune Checkpoint

NCT06470997 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT06470997
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06470997 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Specific Biomarkers of Immune-mediated Hepatitis Secondary to Immune Checkpoint
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Recruiting
Start date
July 17, 2024
Completion date
January 31, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immune-mediated hepatitis